IPG Photonics reported a decline in revenue and net income for the first quarter of 2025 compared to the prior year, primarily due to lower sales in materials processing. However, the company saw growth in medical and advanced applications and achieved revenue, adjusted EPS, and adjusted EBITDA above the midpoint of their guidance. The book-to-bill ratio was above one, indicating positive bookings momentum.
Revenue for Q1 2025 was $227.8 million, a 10% decrease year over year.
GAAP diluted EPS was $0.09, an 83% decrease year over year.
Non-GAAP adjusted diluted EPS was $0.31, a 38% decrease year over year.
Materials processing sales decreased 14% year over year, while other applications sales increased 25%.
For the second quarter of 2025, IPG expects revenue between $210 million and $240 million, adjusted gross margin between 36% and 38%, operating expenses between $86 million and $88 million, adjusted earnings per diluted share in the range of -$0.05 to $0.25, and adjusted EBITDA in the range of $16 million to $31 million.
Visualization of income flow from segment revenue to net income